Unravelling the tumour genome: the evolutionary and clinical impacts of structural variants in tumourigenesis

Alhafidz Hamdan; Ailith Ewing

doi:10.1002/path.5901

Unravelling the tumour genome: the evolutionary and clinical impacts of structural variants in tumourigenesis

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	The Journal of Pathology
DOIs	https://doi.org/10.1002/path.5901
Publication status	Published - 31 Mar 2022

Access to Document

10.1002/path.5901Licence: Other

The Journal of Pathology - 2022 - Hamdan - Unravelling the tumour genome the evolutionary and clinical impacts of
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/path.5901
Accepted author manuscript, 2.61 MB

https://onlinelibrary.wiley.com/doi/10.1002/path.5901

Cite this

@article{f26d1ba475e8477ab8a72d1ba42454af,

title = "Unravelling the tumour genome: the evolutionary and clinical impacts of structural variants in tumourigenesis",

author = "Alhafidz Hamdan and Ailith Ewing",

note = "Funding Information: AH is supported by Cancer Research UK and the Edinburgh Clinical Academic Training (ECAT) programme; AE is supported by a University of Edinburgh Chancellor's Fellowship and core funding from the MRC Human Genetics Unit. Publisher Copyright: {\textcopyright} 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.",

year = "2022",

month = mar,

day = "31",

doi = "10.1002/path.5901",

language = "English",

journal = "The Journal of Pathology",

issn = "0022-3417",

publisher = "Wiley",

}

TY - JOUR

T1 - Unravelling the tumour genome: the evolutionary and clinical impacts of structural variants in tumourigenesis

AU - Hamdan, Alhafidz

AU - Ewing, Ailith

N1 - Funding Information: AH is supported by Cancer Research UK and the Edinburgh Clinical Academic Training (ECAT) programme; AE is supported by a University of Edinburgh Chancellor's Fellowship and core funding from the MRC Human Genetics Unit. Publisher Copyright: © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

PY - 2022/3/31

Y1 - 2022/3/31

U2 - 10.1002/path.5901

DO - 10.1002/path.5901

M3 - Article

SN - 0022-3417

JO - The Journal of Pathology

JF - The Journal of Pathology

ER -